What is InvaPharm?
InvaPharm operates as a comprehensive contract manufacturer, focusing on the production of dietary supplements, vitamins, and nutritional products. With an extensive legacy spanning over 60 years, the company is dedicated to upholding high-quality production standards and delivering exceptional customer service. Their service portfolio encompasses product formulation, manufacturing, packaging, and pilot runs, designed to offer clients a streamlined and efficient process. InvaPharm's state-of-the-art facility and deep understanding of regulatory requirements position them as a trusted partner for brands aiming to succeed in the dynamic supplement industry.
How much funding has InvaPharm raised?
InvaPharm has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for InvaPharm?
The substantial capital raised, particularly the recent strategic investment, signals InvaPharm's readiness for accelerated expansion and enhanced operational capabilities. This financial backing is expected to fuel advancements in manufacturing technology, potentially broaden their service offerings, and strengthen their market penetration. As a company with a long-standing reputation for quality and reliability, this investment will likely enable InvaPharm to further solidify its leadership in the contract manufacturing space for nutritional products, catering to an increasing global demand for health and wellness solutions.
See full InvaPharm company page
